Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection

Travel Med Infect Dis. 2021 Nov-Dec:44:102170. doi: 10.1016/j.tmaid.2021.102170. Epub 2021 Oct 13.

¹ Department of Microbiology, ICMR-Regional Medical Research, Centre Dept. of Health Research, Ministry of Health & Family Welfare, Govt. of India, Chandrasekharpur, Bhubaneswar, 751023, India.
² Department of Microbiology, ICMR-Regional Medical Research, Centre Dept. of Health Research, Ministry of Health & Family Welfare, Govt. of India, Chandrasekharpur, Bhubaneswar, 751023, India. Electronic address: drsanghamitra12@gmail.com.
³ Department of Microbiology, ICMR-Regional Medical Research, Centre Dept. of Health Research, Ministry of Health & Family Welfare, Govt. of India, Chandrasekharpur, Bhubaneswar, 751023, India. Electronic address: drdebdutta.bhattacharya@yahoo.co.in.

No abstract available

Keywords: COVAXIN®; COVID-19; COVISHIELD™; Spike IgG antibody; Vaccination.

Publication types